COSCIENS Biopharma (CSCIF) Q4 2025 Earnings

25MarConfirmed
Q2 2025
Q3 2025
Q4 2025
Q4 2025
-3.48
-2.55
-1.62
-0.69

Details

Expected EPS
N/A
Actual EPS
-0.69
Surprise EPS
-0.69
Surprise Percent
+∞%

Description

COSCIENS Biopharma (CSCIF) has reported earnings of -0.69 per share for Q4 2025.

0 Comments

Share your thoughts